Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
The CDC is soliciting contractor support for two market forecast analyses: one for a human West Nile virus vaccine and one for an anti-WNV monoclonal antibody for prophylaxis. The contractor will perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and prepare peer-reviewed publications. The acquisition will result in a time-and-materials purchase order with a 12-month period of performance from September 30, 2026, to September 29, 2027. Offerors must submit completed pricing, a T&M quotation for the entire period, a written acknowledgement of the Statement of Work, active SAM registration with UEI, and any required AI disclosures.